Association of the variants in AGT gene with modified drug response in Korean aspirin-intolerant asthma patients

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 5, 2011, Pages 595-601

  Pasaje, Charisse Flerida A ^a   Kim, Jeong Hyun ^a   Park, Byung Lae ^b   Cheong, Hyun Sub ^b   Park, Tae Joon ^a   Lee, Jin Sol ^a   Kim, Yongha ^a   Bae, Joon Seol ^a   Kim, Jin Moo ^c   Park, Jong Sook ^c   Park, Choon Sik ^c   Shin, Hyoung Doo ^a,b  

^a Sogang University   (South Korea)

^b SNP Genetics Inc   (South Korea)

^c Soonchunhyang University   (South Korea)

Author keywords

AGT; Aspirin intolerant asthma; Haplotype; MLK; Polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSINOGEN; CYSTEINE; GUANINE; MONTELUKAST; THREONINE;

ADULT; AGED; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; BRONCHOSPASM; COHORT ANALYSIS; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ACETATES; ADOLESCENT; ADULT; AGED; ALGORITHMS; ANGIOTENSINOGEN; ANTI-ASTHMATIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; ASPIRIN; ASTHMA, ASPIRIN-INDUCED; BRONCHIAL SPASM; CASE-CONTROL STUDIES; DRUG HYPERSENSITIVITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; QUINOLINES; REPUBLIC OF KOREA; YOUNG ADULT;

EID: 80052415193     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2011.05.007     Document Type: Article

References (42)

1. Hedman J., Kaprio J., Poussa T., Nieminen M.M. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999, 28:717-722.
2. Spector S.L., Wangaard C.H., Farr R.S. Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J Allergy Clin Immunol 1979, 64:500-506.
3. Sanak M., Szczeklik A. Genetics of aspirin induced asthma. Thorax 2000, 55(Suppl. 2):S45-S47.
4. Marquette C.H., Saulnier F., Leroy O., Wallaert B., Chopin C., Demarcq J.M., et al. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 1992, 146:76-81.
5. Picado C., Castillo J.A., Montserrat J.M., Agusti-Vidal A. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur Respir J 1989, 2:127-129.
6. Nally J.E., Clayton R.A., Wakelam M.J., Thomson N.C., McGrath J.C. Angiotensin II enhances responses to endothelin-1 in bovine bronchial smooth muscle. Pulm Pharmacol 1994, 7:409-413.
7. Millar E.A., Nally J.E., Thomson N.C. Angiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro and in vivo. Eur Respir J 1995, 8:1838-1841.
8. Ramsay S.G., Dagg K.D., McKay I.C., Lipworth B.J., McSharry C., Thomson N.C. Investigations on the renin-angiotensin system in acute severe asthma. Eur Respir J 1997, 10:2766-2771.
9. Millar E.A., Angus R.M., Hulks G., Morton J.J., Connell J.M., Thomson N.C. Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function. Thorax 1994, 49:492-495.
10. Luchtefeld M., Drexler H., Schieffer B. 5-Lipoxygenase is involved in the angiotensin II-induced NAD(P)H-oxidase activation. Biochem Biophys Res Commun 2003, 308:668-672.
11. Mueller C.F., Becher M.U., Zimmer S., Wassmann S., Keuler B., Nickenig G. Angiotensin II triggers release of leukotriene C4 in vascular smooth muscle cells via the multidrug resistance-relatedprotein 1. Mol Cell Biochem 2010, 333:261-267.
12. Sanak M., Simon H.U., Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997, 350:1599-1600.
13. Picado C. Aspirin-intolerant asthma: role of cyclo-oxygenase enzymes. Allergy 2002, 57(Suppl. 72):58-60.
14. Szczeklik A. The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 1990, 3:588-593.
15. Blake K.V. Montelukast: data from clinical trials in the management of asthma. Ann Pharmacother 1999, 33:1299-1314.
16. Krawiec M.E., Wenzel S.E. Use of leukotriene antagonists in childhood asthma. Curr Opin Pediatr 1999, 11:540-547.
17. Park J.S., Jang A.S., Park S.W., Lee Y.M., Uh S.T., Kim Y.H., et al. Protection of leukotriene receptor antagonist against aspirin-inducedbronchospasm in asthmatics. Allergy Asthma Immunol Res 2010, 2:48-54.
18. Kanazawa H., Kurihara N., Hirata K., Kudoh S., Fujii T., Tanaka S., et al. Angiotensin II stimulates peptide leukotriene production by guinea pig airway via the AT1 receptor pathway. Prostaglandins Leukot Essent Fatty Acids 1995, 52:241-244.
19. Crapo R.O., Casaburi R., Coates A.L., Enright P.L., Hankinson J.L., Irvin C.G., et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000, 161:309-329.
20. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
21. Hedrick P.W. Gametic disequilibrium measures: proceed with caution. Genetics 1987, 117:331-341.
22. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004, 74:765-769.
23. Kemp J.P. Exercise-induced bronchoconstriction: the effects of montelukast, a leukotriene receptor antagonist. Ther Clin Risk Manag 2009, 5:923-933.
24. Salvi S.S., Krishna M.T., Sampson A.P., Holgate S.T. The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma. Chest 2001, 119:1533-1546.
25. Yoshida S., Sakamoto H., Ishizaki Y., Onuma K., Shoji T., Nakagawa H., et al. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma. Clin Exp Allergy 2000, 30:64-70.
26. Tan R.A., Spector S.L. Exercise-induced asthma: diagnosis and management. Ann Allergy Asthma Immunol 2002, 89:226-235. quiz 35-7, 97.
27. Dahlen B. Treatment of aspirin-intolerant asthma with antileukotrienes. Am J Respir Crit Care Med 2000, 161:S137-S141.
28. Thomson N.C., Dagg K.D., Ramsay S.G. Humoral control of airway tone. Thorax 1996, 51:461-464.
29. Pagani F., Baralle F.E. Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 2004, 5:389-396.
30. Pagani F., Buratti E., Stuani C., Bendix R., Dork T., Baralle F.E. A new type of mutation causes a splicing defect in ATM. Nat Genet 2002, 30:426-429.
31. Levesque S., Moutquin J.M., Lindsay C., Roy M.C., Rousseau F. Implication of an AGT haplotype in a multigene association study with pregnancy hypertension. Hypertension 2004, 43:71-78.
32. Ramoni R.B., Himes B.E., Sale M.M., Furie K.L., Ramoni M.F. Predictive genomics of cardioembolic stroke. Stroke 2009, 40:S67-S70.
33. Triche E.W., Saftlas A.F., Belanger K., Leaderer B.P., Bracken M.B. Association of asthma diagnosis, severity, symptoms, and treatment with risk of preeclampsia. Obstet Gynecol 2004, 104:585-593.
34. Schanen J.G., Iribarren C., Shahar E., Punjabi N.M., Rich S.S., Sorlie P.D., et al. Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study. Thorax 2005, 60:633-638.
35. Roisman G.L., Danel C.J., Lacronique J.G., Alhenc-Gelas F., Dusser D.J. Decreased expression of angiotensin-converting enzyme in the airway epithelium of asthmatic subjects is associated with eosinophil inflammation. J Allergy Clin Immunol 1999, 104:402-410.
36. Bucknall C.E., Neilly J.B., Carter R., Stevenson R.D., Semple P.F. Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors. Br Med J (Clin Res Ed) 1988, 296:86-88.
37. Kim T.H., Chang H.S., Park S.M., Nam B.Y., Park J.S., Rhim T., et al. Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics. Clin Exp Allergy 2008, 38:1727-1737.
38. Overlack A.A.C.E. inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management. Drug Saf 1996, 15:72-78.
39. Israili Z.H., Hall W.D. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992, 117:234-242.
40. Ozkan M., Dweik R.A., Ahmad M. Drug-induced lung disease. Cleve Clin J Med 2001, 68:782-785. 9-95.
41. Cirulli E.T., Goldstein D.B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010, 11:415-425.
42. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science 1996, 273:1516-1517.